Significance of Background Coloration in Endoscopic Detection of Early Esophageal Squamous Cell Carcinoma
In Japan, squamous cell carcinoma (SCC) accounts for more than 95% of esophageal cancer. Although the incidence of reflux esophagitis has increased, the frequency of esophageal adenocarcinoma has remained immutable, accounting for only about 4% of esophageal cancer [1] . The prognosis of esophageal SCC found in the late stages remains exceedingly poor because of the aggressive nature of the tumor [2] . The proportion of superficial carcinomas among esophageal malignancies in the last 10 years has been approximately 30-35% (Japan Esophageal Society; comprehensive registry of esophageal cancer in Japan; http://esophagus.jp, accessed April 18, 2007) . Although early detection results in better prognosis, it is challenging to detect flat lesions with slight color change. It is exceedingly difficult to find flat lesions, which can be treated using EMR (endoscopic mucosal resection) and ESD (endoscopic submucosal dissection) techniques, with slight color change using a conventional white-light image endoscope.
Chromoendoscopy using iodine has been one of the most reliable diagnostic tools in detecting early SCC of the esophagus [3, 4] . It has been effectively utilized not only in detecting, but also determining the local extent of the tumor. However, iodine spraying often induces unpleasant side effects such as chest discomfort, cough and severe allergic reaction due to its high stimulation. Another issue to be mentioned is that detection of early lesions can be complicated by surrounding severely inflamed mucosa resulting from the patients' habit of drinking and smoking. Therefore, development of new technologies which allow us to obtain diagnostic information without harming patients is required. Recently, significant advancement has been made in the field of image-enhanced endoscopy such as magnifying endoscopy, narrow band imaging (NBI) and Fuji Intelligent Chromo Endoscopy. These newly developed modalities enable us to obtain detailed information of the gastrointestinal tract leading to more reliable evaluation that is consistent with pathological diagnosis.
Historically, several useful classifications, such as Inoue's intrapapillary capillary loop (IPCL) classification [5, 6 ] and Arima's microvascular patterns classification [7] , have been proposed in Japan for diagnosis and evaluation of SCC. However, these two major classifications have been considered to have some difficulties because of their complexity. Thus, the Japan Esophageal Society decided to merge these two classifications into a simpler category that can easily be used in general clinical practice. They introduced the Japanese Classification of Magnifying Endoscopy for Early Squamous Cell Carcinoma as a comprehensive classification of superficial esophageal SCC [8] . Currently, new findings in addition to the vascular structure, such as brownish color change of the epithelia between each IPCL, have been introduced in the esophageal diagnostics. In this review article, we specifically focus on the endoscopic diagnosis of esophageal SCC.
Lugol Chromoendoscopy
Ability to detect early squamous neoplasia of the esophagus can be improved considerably by iodine staining during endoscopic examination, especially for the high-risk population such as an over 50-year-old male with a history of alcohol and tobacco abuse. Iodine-unstained areas usually indicate either inflammatory change, low-grade intraepithelial neoplasia (LGIN), high-grade intraepithelial neoplasia (HGIN), or invasive SCC. Mori et al. [9] analyzed the relationship between Lugol voiding areas and histological features. Their study demonstrated that the staining intensity reflected well the thickness of the glycogen-containing cell layer in the lesion. Furthermore, the sharpness of the margin after staining predicted whether the conversion from glycogen-containing mucosa to noncontaining cell layers was abrupt or gradually changed.
Pink Color Sign/Metallic-Silver Sign
Pink color sign (PCS) was first mentioned by Ohmori and Yokoyama [10] as one of the useful findings for detecting early esophageal neoplasms among multiple Lugol voiding areas in the inflamed esophagus. Shimizu et al. [3] reported that HGIN could be identified as iodineunstained areas that are more distinct and reddish than LGIN when the brown color of iodine solution in the normal region has faded after the staining. This is because there is almost no remaining glycogen-containing epithelium in HGIN. Recognition of PCS in the Lugol voiding area suggests the existence of carcinoma. With NBI, PCS is strongly emphasized and observed as a shiny silver color change, which we call 'metallic silver sign' or 'MSS'.
IPCL Classification
IPCL in the esophagus is usually observed as brown dots under NBI observation. IPCL appears in the plane closely above the muscularis mucosae branched from obliquely running vessels, and is observed as green vessels [11] . Inoue [5] categorized the surface microvasculature of the esophagus into five groups according to the irregularity of shape and degree of each IPCL's dilation. Type I represents normal or minimal change of IPCL. Type I and II usually lack a clear boundary, corresponding to benign pathology including inflammatory change and LGIN. Type III is defined as IPCL with minimal change of caliber, which usually has a clear boundary with background mucosa. Type III are thought to be borderline lesions including LGIN. In contrast, irregularly dilated IPCL with Digestion 2014;89:6-11 DOI: 10.1159/000356200 8 clear area formation is called IPCL type V, which corresponds to malignant pathology including HGIN with high probability. Type IV is the IPCL change between type III and V. Type IV indicates benign change such as LGIN with a probability of approximately 50%. Therefore, the lesions that are categorized into type IV require consideration for removal, which enables further pathological evaluation. Type V is equivalent to definite malignant pathology including HGIN, which basically requires treatment including EMR and ESD. This classification simply offers information of whether the pathological confirmation should be performed by differentiating type III and IV. Recently, Kaga et al. [12] evaluated the detailed vascular structure pathologically and concluded that differences in vessels between IPCL type III and IV are highlighted by two factors: increased vessel caliber and prolongation of IPCLs toward the surface.
Microvascular Patterns of Superficial Esophageal Cancers by Magnifying Endoscopy
Arima et al. [7] classified the microvascular pattern into 4 categories according to the shape and irregularity of the surface microvessels. Type 1 is characterized by thin, linear capillaries in the subepithelial papilla and is generally seen in normal mucosa. Type 2 is characterized by distended, dilated vessels, and the shape of capillaries in the subepithelial papilla is preserved. Type 2 is generally seen in inflammatory lesions. Type 3 is characterized by spiral vessels with an irregular caliber and crushed vessels with red spots, and the arrangement of the vessels is irregular. Type 3 is generally seen in T1a-EP or T1a-LPM cancers. Type 4 has 4 subcategories including multiple layered, irregularly branched, reticular and avascular area (AVA). Type 4 is generally seen in cancers with T1a-MM or deeper invasion. AVAs and stretched type 4 vessels are seen in cancers with downward growth. AVAs were further subcategorized into 3 groups according to the size and it was reported that the size of AVAs was closely related to the depth of tumor invasion [7] . Japanese Classification of Magnifying Endoscopy for Early Squamous Cell Carcinoma (Japan Esophageal Society) [8] However, the two major classifications mentioned above are considered to be somewhat complicated for global use. Therefore, the Japan Esophageal Society decided to create a new simplified classification. The new classification is composed of two major criteria. One is the shape and width of vessels, and the other is the size of the AVA. The vessels observed by magnified endoscopy were classified into two groups, types A and B.
Type A is vessels with mild or no atypia of IPCL. Type B is IPCL with atypia including dilatation, meandering, caliber change and uneven form in each vessel. A lesion with type A strongly suggests intraepithelial neoplasia, whereas type B indicates SCC. Type B was subclassified into 3 groups, and the invasion depth of B1, B2 and B3 was consistent with T1aEP or LPM, T1aMM or T1bSM1 and T1bSM2, respectively. In addition, AVA was divided into three groups according to the tumor size. AVA small, AVA middle and AVA large were defined as 0.5 mm or less, between 0.5 and 3 mm, and 3 mm or larger, respectively. The accuracy of diagnosis using this method was 90%. They concluded that the new classification of magnified endoscopy is simple and useful for diagnosis of invasion depth of esophageal SCC.
Background Coloration
We have reported the importance of the color change in the epithelia between IPCLs (background coloration; BC) in differentiating early SCC in the esophagus from benign lesions including inflammatory changes [13] . The BC has been additionally noted as intravascular BC in the Japanese classification of magnifying endoscopy for early SCC.
Ishihara et al. [14] reported that both the background color change and dilated IPCL was important in diagnosing esophageal SCC among any other early changes such as brownish dots (dilated IPCL), tortuous IPCL, elongated IPCL, caliber change in IPCL, variety in IPCL shapes, demarcation line and protrusion or depression. Also, Kanzaki et al. [15] statistically analyzed the cause of this color change. They reported that it may be related to thinning of the keratinous layer, caused by neoplastic cell proliferation and thinning of the epithelium. However, NBI mechanically reflects the wavelength that is specific to hemoglobin (Hb). Therefore, we have come to realize that the color change might be related to the extravascular Hb component in the cancer area.
Evaluation of BC
After a brownish area in esophagus was found with NBI, the lesions were observed with NBI magnification in order to evaluate the presence of BC. A lesion was record-ed as BC positive when distinct color change in the area between IPCLs was seen. When there was no color change in this area, the lesion was regarded as BC negative.
In our current study including 223 lesions of early pharyngo-esophageal SCC, 194 lesions (86.6%) were BC positive, only 3 (2.5%) of which were pathologically diagnosed as benign ( table 1 ) . Sensitivity, specificity and overall accuracy of BC in differentiating malignancy from benign pathology were 91.1, 71.4 and 89.4%, respectively.
What Makes the Color Change?
The cause of this phenomenon is still unclear. To begin with, NBI is a technique that enables us to exclusively identify the wavelength of Hb. Therefore, we speculated the involvement of intra-or extravascular Hb in the cancer area. We applied an immunohistochemical approach using anti-human Hb antibody to evaluate the correlation between BC and the Hb component. Figure 1 c and d show an immunopathological feature from both the Hbpositive cancerous area and negative surrounding noncancerous area. Preliminary results revealed that there was a significant correlation between Hb immunopositivity and pathology. The rate of correlation between BC and Hb positivity was as high as 80.9%. Interestingly, an immunofluorescent image showed that Hb positivity was mainly observed within cytosol of cancer cells outside of the nuclei with clear boundaries ( fig. 2 a, b) .
Furthermore, real-time polymerase chain reaction, RT-PCR, was performed to quantify the Hb-β expression of both SCC and surrounding noncancerous mucosa. RT-PCR results revealed that the Hb-β mRNA expression rate was three times higher in the cancer area than the surrounding noncancerous area (p < 0.05). In situ hybridization of Hb-β mRNA also confirmed the contribution of Hb-β expression in the cancer areas. These results support the belief that the Hb might be produced inside the cancer cells. The overall accuracy in diagnosing malignancies (HGIN/SCC) from benign change was 90.1% (10 + 191/223). Sensitivity was 91.0% (191/219), specificity was 77.0% (10/13), positive predictive value was 98.5% (191/194) and negative predictive value was 34.5% (10/29). We also conducted immunostaining using anti-human CD68 antibody in order to evaluate the relevancy of macrophages in the cancer area, which may contain hemosiderin that potentially causes the color change ( fig. 3 a-c) . Very few macrophages were observed in the surface area of the lesion whereas immunopositivity for anti-human Hb antibody was clearly seen in the cancer area, which was confirmed with conventional HE staining. This result suggests that the color change is independent from hemosiderin contained by macrophages in the cancer area.
The mechanisms of and the reason for Hb production in the cancer tissues are still obscure. However, many investigators have reported the expression of Hb mRNA in various organs, including both the benign and malignant [16] [17] [18] [19] . A hypoxic environment or oxidant stress may be a justifiable cause for this phenomenon. Also, as Kanzaki et al. [15] reported, the thickness of the keratinous layer and the optical mechanism could be the explanation. Further studies are mandatory to determine the exact cause of BC.
Endocytoscopy
Contact endoscopy was first described by Hamou [20] in 1979 as a method of microhysteroscopy to examine the surface of the genital tract at high magnification. Tada and Uozumi [21] first described the ultra-high magnifying endoscope in the gastrointestinal tract in 1982. Conventional magnification endoscopy enables detailed evaluation of gastrointestinal mucosa. Furthermore, endocytoscopy with ultra-high magnification allows in vivo observation of cellular atypia during routine endoscopic examination [22] [23] [24] . This novel technique opened the door to the possibility of 'optical biopsy', which enables us to obtain pathological diagnosis without taking biopsies. It is predicted that the incidence of cardiovascular or cerebrovascular complications would significantly increase. Optical biopsy using endocytoscopy will be of great help in the sense of saving time, money and perioperative risk due to interruption of anticoagulant therapy. The establishment of common diagnostic criteria of endocytoscopy imaging is essentially required. 
Conclusion
Recent advancement in the technology of image-enhanced endoscopy allows us to evaluate in detail the surface structure of the gastrointestinal tract. With the introduction of a newly constructed classification by the Japan Esophageal Society, diagnostics of esophageal SCC could be united and spread widely. Also, many studies with the purpose of illuminating the underlying mechanism and determining the significance of each finding have been conducted. It is important that we understand both the characteristics of the devices and the meaning of each finding comprehensively and precisely.
